US2021187017A1PendingUtilityA1

Composition and method for the prevention and treatment of obesity

60
Assignee: VECTOR VITALE IP LLCPriority: Dec 20, 2019Filed: Oct 6, 2020Published: Jun 24, 2021
Est. expiryDec 20, 2039(~13.4 yrs left)· nominal 20-yr term from priority
A61K 31/197A61K 9/0019A61K 9/0053A61K 33/30
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for reducing the weight of an overweight or obese subject comprising administering a therapeutically effective amount of a composition comprising 64Zn-enriched zinc. A method for preventing or reducing weight gain comprising administering an effective amount of a composition comprising 64Zn-enriched zinc.

Claims

exact text as granted — not AI-modified
1 . A method of preventing overweightness or obesity comprising administering to a subject in need thereof a prophylactically or therapeutically effective amount composition comprising a  64 Zn e  compound or a salt thereof, wherein the  64 Zn e  compound or a salt thereof is at least 80%  64 Zn e . 
     
     
         2 . The method of  claim 1 , wherein the composition further comprises a diluent or an excipient. 
     
     
         3 . The method of  claim 2 , wherein the diluent is deuterium-depleted water. 
     
     
         4 . The method of  claim 1 , wherein the  64 Zn e  compound or a salt thereof is at least 95%  64 Zn e . 
     
     
         5 . The method of  claim 1 , wherein the  64 Zn e  compound or a salt thereof is at least 99%  64 Zn e . 
     
     
         6 . The method of  claim 1 , wherein the composition contains between 0.05 mg and 110 mg of  64 Zn e . 
     
     
         7 . The method of  claim 6 , wherein the composition contains between 1 and 10 mg of  64 Zn e . 
     
     
         8 . The method of  claim 1 , wherein the  64 Zn e  compound or a salt thereof is at least 90%  64 Zn e  and the composition is an aqueous solution in which  64 Zn e  is present at a concentration of between 0.1 mg/ml and 10 mg/ml. 
     
     
         9 . The method of  claim 1 , wherein  64 Zn e  is in a form of salt selected from the group consisting of zinc aspartate with 2 aspartic acid molecules, zinc sulfate, and zinc citrate wherein the zinc aspartate has the structure 
       
         
           
           
               
               
           
         
       
     
     
         10 . The method of  claim 1 , wherein the composition is administered by injection. 
     
     
         11 . The method of  claim 1 , wherein the composition is administered orally. 
     
     
         12 . A method of treating overweightness or obesity comprising administering to a subject in need thereof a prophylactically or therapeutically effective amount composition comprising a  64 Zn e  compound or a salt thereof, wherein the  64 Zn e  compound or a salt thereof is at least 80%  64 Zn e , wherein  64 Zn e  is in a form of salt selected from the group consisting of zinc aspartate with 2 aspartic acid molecules, zinc sulfate, and zinc citrate, wherein the zinc aspartate has the structure

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.